2020 Joint ACTRIMS-ECTRIMS Meeting

Biogen is participating in the 2020 Joint ACTRIMS-ECTRIMS Meeting, called MSVirtual2020. 

Below is the agenda for the Biogen Virtual Symposium (Non-CME Presentation)

COVID-19 and MS: Lessons (to be) learned from the pandemic

Agenda (CEST)


Welcome and opening

Gavin Giovannoni, Barts and The London School of Medicine and Dentistry, London, UK


What happens when COVID-19 meets the flu season?
A virologist perspective

Roberto Burioni, Vita-Salute San Raffaele University, Milan, Italy


How did MS patients do with COVID-19?
A data scientist perspective

Liesbet Peeters, Hasselt University, Hasselt, Belgium


Will COVID-19 change the way we manage MS?
A neurologist perspective

Xavier Montalban, Multiple Sclerosis Centre of Catalonia (CEMCAT), Barcelona, Spain


Managing MS in an evolving COVID-19 world
Round table discussion

Thomas Berger, Medical University of Vienna, Vienna, Austria


Q&A and closing

Gavin Giovannoni

2020 is the year in which COVID-19 emerged as a global health crisis. How can we anticipate its effect during the upcoming flu season? What impact does it have on MS patients, and on the management of MS?
Join our symposium, as the expert faculty discuss the lessons learned from the pandemic, and the lessons still to be learned.

Submit your interest to receive notifications before the Symposium starts and other business-related communications which may of interest to you.

Information on how Biogen processes the personal data of healthcare professionals and your rights in relation to this can be found in our Healthcare Professional Privacy Notice at https://www.biogen.com/en_us/privacy-international.html

After you submit your interest you will be taken to the 2020 Joint ACTRIMS-ECTRIMS Meeting website to register.